This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davignon, J. L.
Right arrow Articles by Davrinche, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davignon, J. L.
Right arrow Articles by Davrinche, C.

 Previous Article  |  Next Article 

J. Virol., Apr 1996, 2162-2169, Vol 70, No. 4
Copyright © 1996, American Society for Microbiology

Anti-human cytomegalovirus activity of cytokines produced by CD4+ T- cell clones specifically activated by IE1 peptides in vitro

JL Davignon, P Castanie, JA Yorke, N Gautier, D Clement and C Davrinche
Institut National de la Sante et de la Recherche Medicale U 395, Centre Hospitalier Universitaire Purpan, Toulouse, France.

The control of latent cytomegalovirus (CMV) infections by the immune system is poorly understood. We have previously shown that CD4+ T cells specific for the human CMV major regulatory protein IE1 are frequent in latently infected healthy blood donors. In order to learn about the possible role of these cells, we have developed IE1-specific CD4+ T- cell clones and, in this study, analyzed their epitope specificity and function in vitro. We measured their cytokine production when stimulated with specific IE1 peptides or whole recombinant IE1 protein. Their cytokine profiles, as deduced from gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and interleukin-4 (IL-4) and IL-6 production, were of the Th0- and Th1-like phenotypes. Supernatants from IE1-specific clones producing IFN-gamma and TNF-alpha were shown to inhibit CMV replication in U373 MG cells. This effect was due, as found by using cytokine-specific neutralizing antibodies, mostly to IFN- gamma, which was secreted at higher levels than TNF-alpha. To better assess the anti-CMV activity of cytokines, recombinant IFN-gamma and TNF-alpha were used and shown to have a synergistic effect on the inhibition of CMV replication and protein expression. Thus, IE1- specific CD4+ T cells display in vitro anti-CMV activity through cytokine secretion and may play a role in the control of in vivo latent infections.


This article has been cited by other articles:

  • Bartee, E., Mohamed, M. R., Lopez, M. C., Baker, H. V., McFadden, G. (2009). The Addition of Tumor Necrosis Factor plus Beta Interferon Induces a Novel Synergistic Antiviral State against Poxviruses in Primary Human Fibroblasts. J. Virol. 83: 498-511 [Abstract] [Full Text]  
  • Crough, T., Khanna, R. (2009). Immunobiology of Human Cytomegalovirus: from Bench to Bedside. Clin. Microbiol. Rev. 22: 76-98 [Abstract] [Full Text]  
  • Baron, M., Davignon, J.-L. (2008). Inhibition of IFN-{gamma}-Induced STAT1 Tyrosine Phosphorylation by Human CMV Is Mediated by SHP2. J. Immunol. 181: 5530-5536 [Abstract] [Full Text]  
  • Mersseman, V., Besold, K., Reddehase, M. J., Wolfrum, U., Strand, D., Plachter, B., Reyda, S. (2008). Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies. J. Gen. Virol. 89: 369-379 [Abstract] [Full Text]  
  • Delmas, S., Brousset, P., Clement, D., Le Roy, E., Davignon, J.-L. (2007). Anti-IE1 CD4+ T-cell clones kill peptide-pulsed, but not human cytomegalovirus-infected, target cells. J. Gen. Virol. 88: 2441-2449 [Abstract] [Full Text]  
  • Delmas, S., Martin, L., Baron, M., Nelson, J. A., Streblow, D. N., Davignon, J.-L. (2005). Optimization of CD4+ T Lymphocyte Response to Human Cytomegalovirus Nuclear IE1 Protein through Modifications of Both Size and Cellular Localization. J. Immunol. 175: 6812-6819 [Abstract] [Full Text]  
  • Weekes, M. P., Wills, M. R., Sissons, J. G. P., Carmichael, A. J. (2004). Long-Term Stable Expanded Human CD4+ T Cell Clones Specific for Human Cytomegalovirus Are Distributed in Both CD45RAhigh and CD45ROhigh Populations. J. Immunol. 173: 5843-5851 [Abstract] [Full Text]  
  • Li Pira, G., Bottone, L., Ivaldi, F., Pelizzoli, R., Del Galdo, F., Lozzi, L., Bracci, L., Loregian, A., Palu, G., De Palma, R., Einsele, H., Manca, F. (2004). Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution. Int Immunol 16: 635-642 [Abstract] [Full Text]  
  • Popkin, D. L., Watson, M. A., Karaskov, E., Dunn, G. P., Bremner, R., Virgin, H. W. IV (2003). Murine cytomegalovirus paralyzes macrophages by blocking IFN{gamma}-induced promoter assembly. Proc. Natl. Acad. Sci. USA 100: 14309-14314 [Abstract] [Full Text]  
  • Popkin, D. L., Virgin, H. W. IV (2003). Murine Cytomegalovirus Infection Inhibits Tumor Necrosis Factor Alpha Responses in Primary Macrophages. J. Virol. 77: 10125-10130 [Abstract] [Full Text]  
  • Odeberg, J., Plachter, B., Branden, L., Soderberg-Naucler, C. (2003). Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR {alpha}-chain. Blood 101: 4870-4877 [Abstract] [Full Text]  
  • Cheeran, M. C.-J., Hu, S., Sheng, W. S., Peterson, P. K., Lokensgard, J. R. (2003). CXCL10 Production from Cytomegalovirus-Stimulated Microglia Is Regulated by both Human and Viral Interleukin-10. J. Virol. 77: 4502-4515 [Abstract] [Full Text]  
  • Le Roy, E., Baron, M., Faigle, W., Clement, D., Lewinsohn, D. M., Streblow, D. N., Nelson, J. A., Amigorena, S., Davignon, J.-L. (2002). Infection of APC by Human Cytomegalovirus Controlled Through Recognition of Endogenous Nuclear Immediate Early Protein 1 by Specific CD4+ T Lymphocytes. J. Immunol. 169: 1293-1301 [Abstract] [Full Text]  
  • Cebulla, C. M., Miller, D. M., Zhang, Y., Rahill, B. M., Zimmerman, P., Robinson, J. M., Sedmak, D. D. (2002). Human Cytomegalovirus Disrupts Constitutive MHC Class II Expression. J. Immunol. 169: 167-176 [Abstract] [Full Text]  
  • Arrode, G., Boccaccio, C., Abastado, J.-P., Davrinche, C. (2002). Cross-Presentation of Human Cytomegalovirus pp65 (UL83) to CD8+ T Cells Is Regulated by Virus-Induced, Soluble-Mediator-Dependent Maturation of Dendritic Cells. J. Virol. 76: 142-150 [Abstract] [Full Text]  
  • Vaz-Santiago, J., Lule, J., Rohrlich, P., Jacquier, C., Gibert, N., Le Roy, E., Betbeder, D., Davignon, J.-L., Davrinche, C. (2001). Ex Vivo Stimulation and Expansion of both CD4+ and CD8+ T Cells from Peripheral Blood Mononuclear Cells of Human Cytomegalovirus-Seropositive Blood Donors by Using a Soluble Recombinant Chimeric Protein, IE1-pp65. J. Virol. 75: 7840-7847 [Abstract] [Full Text]  
  • Odeberg, J., Söderberg-Nauclér, C. (2001). Reduced Expression of HLA Class II Molecules and Interleukin-10- and Transforming Growth Factor {beta}1-Independent Suppression of T-Cell Proliferation in Human Cytomegalovirus-Infected Macrophage Cultures. J. Virol. 75: 5174-5181 [Abstract] [Full Text]  
  • Presti, R. M., Popkin, D. L., Connick, M., Paetzold, S., Virgin, H. W. IV (2001). Novel Cell Type-Specific Antiviral Mechanism of Interferon {gamma} Action in Macrophages. JEM 193: 483-496 [Abstract] [Full Text]  
  • Arrode, G., Boccaccio, C., Lulé, J., Allart, S., Moinard, N., Abastado, J.-P., Alam, A., Davrinche, C. (2000). Incoming Human Cytomegalovirus pp65 (UL83) Contained in Apoptotic Infected Fibroblasts Is Cross-Presented to CD8+ T Cells by Dendritic Cells. J. Virol. 74: 10018-10024 [Abstract] [Full Text]  
  • Cheeran, M. C.-J., Gekker, G., Hu, S., Yager, S. L., Peterson, P. K., Lokensgard, J. R. (2000). CD4+ Lymphocyte-Mediated Suppression of Cytomegalovirus Expression in Human Astrocytes. CVI 7: 710-713 [Abstract] [Full Text]  
  • Herbein, G., O'brien, W. A. (2000). Tumor Necrosis Factor (TNF)-{alpha} and TNF Receptors in Viral Pathogenesis. Exp. Biol. Med. 223: 241-257 [Abstract] [Full Text]  
  • Cheeran, M. C.-J., Hu, S., Gekker, G., Lokensgard, J. R. (2000). Decreased Cytomegalovirus Expression Following Proinflammatory Cytokine Treatment of Primary Human Astrocytes. J. Immunol. 164: 926-933 [Abstract] [Full Text]  
  • Le Roy, E., Mühlethaler-Mottet, A., Davrinche, C., Mach, B., Davignon, J.-L. (1999). Escape of Human Cytomegalovirus from HLA-DR-Restricted CD4+ T-Cell Response Is Mediated by Repression of Gamma Interferon-Induced Class II Transactivator Expression. J. Virol. 73: 6582-6589 [Abstract] [Full Text]  
  • Gagnon, S. J., Ennis, F. A., Rothman, A. L. (1999). Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones. J. Virol. 73: 3623-3629 [Abstract] [Full Text]  
  • Boyle, K. A., Pietropaolo, R. L., Compton, T. (1999). Engagement of the Cellular Receptor for Glycoprotein B of Human Cytomegalovirus Activates the Interferon-Responsive Pathway. Mol. Cell. Biol. 19: 3607-3613 [Abstract] [Full Text]  
  • Presti, R. M., Pollock, J. L., Dal Canto, A. J., O'Guin, A. K., Virgin, H. W. IV (1998). Interferon {gamma} Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great Vessels. JEM 188: 577-588 [Abstract] [Full Text]  
  • Miller, D. M., Rahill, B. M., Boss, J. M., Lairmore, M. D., Durbin, J. E., Waldman, J. W., Sedmak, D. D. (1998). Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway. JEM 187: 675-683 [Abstract] [Full Text]  
  • Allan-Yorke, J., Record, M., de Preval, C., Davrinche, C., Davignon, J.-L. (1998). Distinct Pathways for Tumor Necrosis Factor Alpha and Ceramides in Human Cytomegalovirus Infection. J. Virol. 72: 2316-2322 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»